Dermatologic events from EGFR inhibitors: the issue of the missing patient voice

被引：0
|
作者：
Bernd Tischer
Renate Huber
Matthias Kraemer
Mario E. Lacouture
机构：
[1] Kantar Health,Dermatology Service, Department of Medicine
[2] Merck KGgA,undefined
[3] Memorial Sloan Kettering Cancer Center,undefined
来源：
Supportive Care in Cancer | 2017年 / 25卷
关键词：
Dermatologic adverse events; EGFR inhibitors; Health-related quality of life; Skin rash;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：651 / 660
页数：9
相关论文
共 50 条
  • [41] Rash From EGFR Inhibitors: Opportunities and Challenges for Palliation
    Solomon, Benjamin M.
    Jatoi, Aminah
    CURRENT ONCOLOGY REPORTS, 2008, 10 (04) : 304 - 308
  • [42] Rash from EGFR inhibitors: Opportunities and challenges for palliation
    Benjamin M. Solomon
    Aminah Jatoi
    Current Oncology Reports, 2008, 10 : 304 - 308
  • [43] Identification and Optimization of Novel Cathepsin C Inhibitors Derived from EGFR Inhibitors
    Hou, Weijie
    Sun, Huan
    Ma, Yongfen
    Liu, Chunyan
    Zhang, Zhiyuan
    JOURNAL OF MEDICINAL CHEMISTRY, 2019, 62 (12) : 5901 - 5919
  • [44] Voice of cancer patient: Analysis of breast cancer patients' experience with PARP inhibitors
    Aggarwal, S.
    Sharma, R.
    Singh, M.
    Aggarwal, A.
    CANCER RESEARCH, 2019, 79 (04)
  • [45] From the ARCHIVE The mysterious tale of a missing Stradivari, from the January 1900 issue
    不详
    STRAD, 2020, 131 (1557): : 109 - 109
  • [46] Cutaneous adverse events following treatment with third-generation EGFR tyrosine kinase inhibitors
    Li Pomi, Federica
    Vaccaro, Federico
    Borgia, Francesco
    Irrera, Natasha
    Vaccaro, Mario
    ITALIAN JOURNAL OF DERMATOLOGY AND VENEREOLOGY, 2024, 159 (02) : 212 - 214
  • [47] A systematic review of patient-reported outcome instruments of dermatologic adverse events associated with targeted cancer therapies
    Chan, Alexandre
    Cameron, Michael C.
    Garden, Benjamin
    Boers-Doets, Christine B.
    Schindler, Katja
    Epstein, Joel B.
    Choi, Jennifer
    Beamer, Laura
    Roeland, Eric
    Russi, Elvio G.
    Bensadoun, Rene-Jean
    Teo, Yi Ling
    Chan, Raymond J.
    Shih, Vivianne
    Bryce, Jane
    Raber-Durlacher, Judith
    Gerber, Peter Arne
    Freytes, Cesar O.
    Rapoport, Bernardo
    LeBoeuf, Nicole
    Sibaud, Vincent
    Lacouture, Mario E.
    SUPPORTIVE CARE IN CANCER, 2015, 23 (08) : 2231 - 2244
  • [48] Variability in the reporting of dermatologic adverse reactions (dADRs) to EGFR inhibitors cetuximab (C) and panitumumab (P) in the treatment of metastatic colorectal cancer (mCRC)
    Hammerman, S. B.
    West, D. P.
    Bennett, C. L.
    Lacouture, M. E.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [49] Handling missing values in patient-reported outcome data in the presence of intercurrent events
    Thomassen, Doranne
    Roychoudhury, Satrajit
    Amdal, Cecilie Delphin
    Reynders, Dries
    Musoro, Jammbe Z.
    Sauerbrei, Willi
    Goetghebeur, Els
    le Cessie, Saskia
    SISAQOL IMI Work Package, Rajesh
    BMC MEDICAL RESEARCH METHODOLOGY, 2025, 25 (01)
  • [50] A systematic review of patient-reported outcome instruments of dermatologic adverse events associated with targeted cancer therapies
    Alexandre Chan
    Michael C. Cameron
    Benjamin Garden
    Christine B. Boers-Doets
    Katja Schindler
    Joel B. Epstein
    Jennifer Choi
    Laura Beamer
    Eric Roeland
    Elvio G. Russi
    René-Jean Bensadoun
    Yi Ling Teo
    Raymond J. Chan
    Vivianne Shih
    Jane Bryce
    Judith Raber-Durlacher
    Peter Arne Gerber
    César O. Freytes
    Bernardo Rapoport
    Nicole LeBoeuf
    Vincent Sibaud
    Mario E. Lacouture
    Supportive Care in Cancer, 2015, 23 : 2231 - 2244
12345